论文部分内容阅读
目的:评价组织型纤维酶原激活物(r-t PA)对急性脑梗死患者静脉溶栓的临床疗效。方法:选取2013年9月—2014年12月收治的急性脑梗死患者96例,所有患者在入院时经初步确诊,均符合《急性脑卒中接诊后诊断及处理》要求,然后根据患者情况以及意愿,将其分为观察组(50例)与对照组(46例);对照组患者给予常规方法治疗,观察组患者则在此基础上加用r-t PA静脉溶栓治疗,评价两组患者治疗后溶栓的总有效率。结果:观察组患者治疗后的总有效率为88.00%高于对照组为65.22%(P<0.05)。结论:采用r-t PA静脉溶栓治疗急性脑梗死患者的溶栓疗效较为确切。
Objective: To evaluate the clinical effect of tissue-type plasminogen activator (r-t PA) on venous thrombolysis in patients with acute cerebral infarction. Methods: A total of 96 patients with acute cerebral infarction who were admitted from September 2013 to December 2014 were selected. All patients were initially diagnosed at admission and met the requirements of “diagnosis and treatment after acute stroke consultation”, and then according to the patient’s condition and Willingness to be divided into the observation group (50 cases) and the control group (46 cases); control group patients given conventional treatment, the observation group was based on the addition of rt PA intravenous thrombolytic therapy, evaluation of two groups of patients treatment The total effective rate after thrombolysis. Results: The total effective rate of the observation group after treatment was 88.00% higher than that of the control group (65.22%, P <0.05). Conclusion: Thrombolytic therapy in patients with acute cerebral infarction using r-t PA intravenous thrombolysis is more accurate.